We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

LAMP Malaria Test Detects Less-Diagnosed Species

By LabMedica International staff writers
Posted on 16 May 2019
Print article
Image: The HumaLoop M: The easy-to-use Loopamp technology for primary and district laboratories (Photo courtesy of Human Diagnostics).
Image: The HumaLoop M: The easy-to-use Loopamp technology for primary and district laboratories (Photo courtesy of Human Diagnostics).
A new loop-mediated isothermal amplification (LAMP) molecular assay has been developed that can detect Plasmodium vivax, a species of the parasite that causes malaria.

Almost all molecular tests currently available detect P. falciparum, in part because it causes the highest mortality of the different species. However, P. vivax is actually more widespread, with more than 2.5 billion people at risk of infection.

The new LAMP assay was evaluated recently in Colombia using a protocol of consecutive testing, a pan-plasmodium LAMP test followed by the P. vivax test, with polymerase chain reaction (PCR)-based testing as the comparator. In all, 365 fingerpick blood samples from patients with fever were evaluated, and the P. vivax test showed a sensitivity of approximately 94% and a specificity of 92%. Importantly, the test also has a low limit of detection of around one to two parasites per microliter of patient sample.

The LAMP assay was developed by Eiken Chemical (Tokyo, Japan) with the collaboration of The Foundation for Innovative New Diagnostics (FIND, Geneva, Switzerland) who coordinated laboratory testing in collaboration with the Hospital for Tropical Diseases (London, UK). FIND has negotiated pricing for the Loopamp tests and HumaTurb system, with a kit of 96 P. vivax tests costing EUR 499.20 (USD 560) and the HumaTurb costing EUR 15,900. There is also a solution for lower-throughput settings called HumaLoop that is a lower cost.

Xavier C. Ding, PhD, the team leader for malaria diagnostics at FIND, said, “It's only recently that there is a recognition that if we are ever to eliminate malaria, we also need some vivax-specific tests, because that species has its own biological specificities and is much more challenging to eliminate that falciparum.” This is because, unlike P. falciparum, P. vivax can lie dormant in the liver of an infected person in a stage called a hypnozoite, and a person with hypnozoites is then prone to relapsing malarial disease. Dr. Ding added, “There is big hope that this will make it easier and more accessible to get treatment for liver-stage parasites, but that also means you also need good diagnostic tools to identify those people who have vivax.”

Related Links:
Eiken Chemical
The Foundation for Innovative New Diagnostics
Hospital for Tropical Diseases

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.